Publications

• Characterizing the Multidimensional Relationship Between Spirituality and Obsessive-Compulsive Disorder: Thematic Analysis.Sun NY, Guerra SE, Patil MM, Chakravadhanula SS, Pittenger C, Ching T. JMIR Form Res. 2026 Feb 5; 2026 Feb 5. PMID: 41643056.
• Biological Mechanisms and Treatment of Obsessive-Compulsive Disorder.Pittenger C. Annu Rev Clin Psychol. 2026 Feb 5; 2026 Feb 5. PMID: 41642244.
• Classifying Obsessive-Compulsive Disorder from Resting-State EEG Using Convolutional Neural Networks: A Pilot Study.Zaboski B, Fineberg S, Skosnik P, Kichuk S, Fitzpatrick M, Pittenger C. Comput Psychiatr. 2026; 2026 Jan 16. PMID: 41585367.
• Potentially Problematic Research Practices in a Study on Ketamine for Pediatric Depression: Response to Plöderl and Moncrieff.Bloch MH, Dwyer JB. Am J Psychiatry. 2026 Jan 1; 2026 Jan 1. PMID: 41476337.
• Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study.Kosik-Gonzalez C, Fu DJ, Chen LN, Lane R, Bloch MH, DelBello M, Moreno C, Drevets WC, Canuso CM. J Am Acad Child Adolesc Psychiatry. 2026 Jan; 2025 Mar 7. PMID: 40058488.
• Racial, Ethnic and Sex Representation in Tourette's Syndrome Clinical Trials: A Meta-Analysis.Behling E, Farhat LC, Landeros-Weisenberger A, Bloch MH. Mov Disord Clin Pract. 2025 Dec 15; 2025 Dec 15. PMID: 41392858.
• Distinguishing Suicidal Obsessions from Suicidal Ideation: A First-Person Suicide Image Pilot Study.Mattera EF, Sandoval K, Sipper C, Fitzpatrick M, Allen A, Pease J, Schild S, Ulaba-Samura Y, Cha C, Pittenger C, Zaboski BA. J Affect Disord. 2025 Dec 15; 2025 Jul 15. PMID: 40675259.
• How to Probe Dynamics of Brain Function: A Narrative Review.Pushkarskaya H, Krishnaswamy S, Pittenger C. Biol Psychiatry. 2025 Dec 8; 2025 Dec 8. PMID: 41371462.
• Editorial: Are we too high on medicinal cannabis in child psychiatry? Examining the evidence in Tourette syndrome.Hardeman LS, Farhat LC, Koenig J, Bloch MH. J Child Psychol Psychiatry. 2025 Dec; 2025 Nov 11. PMID: 41216975.
• The imagery rescripting protocol for obsessive-compulsive disorder (ImRs-OCD): A decade of iterative refinement in treatment sequencing following ERP.Maloney G, Arntz A, Pittenger C. Behav Res Ther. 2025 Dec; 2025 Oct 2. PMID: 41092684.
• Psychotic symptoms during pharmacological treatment of ADHD: clinical considerations and research needs.Cortese S, Garcia-Argibay M, Oliver D, Chang Z, Farhat LC, Bloch MH, de Pablo GS, Larsson H, Solmi M, Correll CU, Fusar-Poli P. Lancet Psychiatry. 2025 Oct 17; 2025 Oct 17. PMID: 41115444.
• Rare coding mutations identify 36 large-effect risk genes in obsessive-compulsive disorder and chronic tic disorders.Wang B, Tran MN, Wang S, Liu Y, Olfson E, Wang G, Sun N, Dea J, Olwal CO, Bertolace L, Bloch MH, Cappi C, Chang YC, Chavira D, Coffey BJ, Falkenstein MJ, Frank AC, Franklin ME, Garayalde S, Garrido H, Grados M, Hatem R, Howell AL, Khim S, Kuckertz JM, Le MM, Libby A, McCarty RJ, McNamara ME, McNeil D, Miguel EC, Nasello C, Nguyen B, Norbu T, Oh L, Ordway A, Paciotti C, Peskin VA, Pittenger C, Simpson HB, Martin HS, Tischfield MA, Xing J, Zakrzewski JJ, Dietrich A, Gilbert DL, Hoekstra PJ, Kim YS, Kuperman S, Rosen A, Zinner SH, Bouhaddou M, King RA, Rouleau G, Ressler KJ, Mathews CA, Krogan NJ, Sestan N, Tischfield JA, Lee AM, Heiman GA, Fernandez TV, Willsey AJ, State MW. medRxiv. 2025 Oct 14; 2025 Oct 14. PMID: 41282685.
• Investigator Meditation Practice Predicts Efficacy of Child/Adolescent Mindfulness-Based Interventions: A Meta-Analysis.Saunders DC, Suzuki S, Vafaie N, Bloch MH, Kober H. Psychother Psychosom. 2025 Oct 7; 2025 Oct 7. PMID: 41056204.
• Effects of Age and BMI on Histamine H3 Receptor Availability in Healthy Humans.Yang Y, Ibrahim W, Gravel P, Pittman B, Hoye J, Cool R, Sadabad FE, Zheng MQ, Pittenger C, Gallezot JD, Carson RE, Huang H, Radhakrishnan R, Matuskey D. Mol Imaging Biol. 2025 Oct; 2025 Sep 12. PMID: 40938339.
• Classifying Obsessive-Compulsive Disorder from Resting-State EEG using Convolutional Neural Networks: A Pilot Study.Zaboski BA, Fineberg SK, Skosnik PD, Kichuk S, Fitzpatrick M, Pittenger C. medRxiv. 2025 Sep 29; 2025 Sep 29. PMID: 40385410.
• Beta bursts mediate amygdala gating of hippocampal emotional encoding.Zhou Y, Huang Y, Pittaro G, Zareian B, Aljishi A, Toro AP, Zibly Z, Obaid S, Sivaraju A, Harpaz-Rotem I, Kaye A, Krystal J, Sheth K, Gu X, Pittenger C, Damisah EC. bioRxiv. 2025 Sep 27; 2025 Sep 27. PMID: 41040163.
• A genomic study of trichotillomania and excoriation disorder in families.Greenspun SR, Milanes I, Farhat LC, Abdallah S, Bok D, Chen D, Liu W, Teefe E, Bloch MH, Fernandez TV, Olfson E. medRxiv. 2025 Sep 24; 2025 Sep 24. PMID: 41040707.
• Moderators of Response to Stimulants for Preschool Attention-Deficit/Hyperactivity Disorder.Farhat LC, Sugaya LS, Bloch MH, Childress A, Cortese S, Fatori D, Salum GA, Rohde LA, Polanczyk GV. J Am Acad Child Adolesc Psychiatry. 2025 Sep 18; 2025 Sep 18. PMID: 40975435.
• The metacognitive paradox of OCD: confidence is globally reduced but shows increased sensitivity to local evidence.Loosen AM, Zaboski BA, Moore A, Bohner C, Pushkarskaya H, Pittenger C, Hauser TU. Res Sq. 2025 Sep 16; 2025 Sep 16. PMID: 41001530.
• #OCD: A Content Analysis of Obsessive-Compulsive Disorder Stereotype Amplification and Misinformation on TikTok.Fitzpatrick M, Moore AS, Kichuk SA, Pittenger C, Zaboski BA. Cyberpsychol Behav Soc Netw. 2025 Sep; 2025 Aug 22. PMID: 40842159.
• Associations between childhood interactions with people of Black race/ethnicity and racial implicit association tasks in psychiatric providers in the United States - a cross-sectional study.Avila-Quintero VJ, Malison K, Wilkerson M, Flores JM, Taylor JH, Landeros-Weisenberger A, Bloch MH, Londoño Tobón A. Child Adolesc Ment Health. 2025 Sep; 2025 Jun 26. PMID: 40574470.
• Editorial: Where Are the Trials on Adolescent Self-Harm and Suicide?Kumpf KT, Bloch MH. J Am Acad Child Adolesc Psychiatry. 2025 Sep; 2025 Mar 13. PMID: 40088968.
• Investigating the familiality of trichotillomania and excoriation disorder.Chen D, Farhat LC, Lebowitz ER, Silverman WK, Bloch MH, Fernandez TV, Olfson E. Psychiatry Res. 2025 Aug; 2025 May 24. PMID: 40449230.
• Letter: Food and Drug Administration Clearance of Transcranial Magnetic Stimulation for Adolescent Depression in the Absence of Data Supporting Efficacy.Kumpf KT, Hughes M, Bloch MH. J Child Adolesc Psychopharmacol. 2025 Aug; 2025 Apr 25. PMID: 40275809.
• Deep learning in obsessive-compulsive disorder: a narrative review.Zaboski BA, Bednarek L, Ayoub K, Pittenger C. Front Psychiatry. 2025; 2025 Jun 13. PMID: 40585546.
• Sex Differences in Histamine Regulation of Striatal Dopamine.Van Zandt M, Pittenger C. J Neurosci. 2025 Jun 11; 2025 Jun 11. PMID: 40355265.
• Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.Strom NI, Gerring ZF, Galimberti M, Yu D, Halvorsen MW, Abdellaoui A, Rodriguez-Fontenla C, Sealock JM, Bigdeli T, Coleman JR, Mahjani B, Thorp JG, Bey K, Burton CL, Luykx JJ, Zai G, Alemany S, Andre C, Askland KD, Bäckman J, Banaj N, Barlassina C, Nissen JB, Bienvenu OJ, Black D, Bloch MH, Børte S, Bosch R, Breen M, Brennan BP, Brentani H, Buxbaum JD, Bybjerg-Grauholm J, Byrne EM, Cabana-Dominguez J, Camarena B, Camarena A, Cappi C, Carracedo A, Casas M, Cavallini MC, Ciullo V, Cook EH, Crosby J, Cullen BA, De Schipper EJ, Delorme R, Djurovic S, Elias JA, Estivill X, Falkenstein MJ, Fundin BT, Garner L, Gironda C, Goes FS, Grados MA, Grove J, Guo W, Haavik J, Hagen K, Harrington K, Havdahl A, Höffler KD, Hounie AG, Hucks D, Hultman C, Janecka M, Jenike E, Karlsson EK, Kelley K, Klawohn J, Krasnow JE, Krebs K, Lange C, Lanzagorta N, Levey D, Lindblad-Toh K, Macciardi F, Maher B, Mathes B, McArthur E, McGregor N, McLaughlin NC, Meier S, Miguel EC, Mulhern M, Nestadt PS, Nurmi EL, O'Connell KS, Osiecki L, Ousdal OT, Palviainen T, Pedersen NL, Piras F, Piras F, Potluri S, Rabionet R, Ramirez A, Rauch S, Reichenberg A, Riddle MA, Ripke S, Rosário MC, Sampaio AS, Schiele MA, Skogholt AH, Sloofman LG, Smit J, Artigas MS, Thomas LF, Tifft E, Vallada H, van Kirk N, Veenstra-VanderWeele J, Vulink NN, Walker CP, Wang Y, Wendland JR, Winsvold BS, Yao Y, Zhou H, Agrawal A, Alonso P, Berberich G, Bucholz KK, Bulik CM, Cath D, Denys D, Eapen V, Edenberg H, Falkai P, Fernandez TV, Fyer AJ, Gaziano JM, Geller DA, Grabe HJ, Greenberg BD, Hanna GL, Hickie IB, Hougaard DM, Kathmann N, Kennedy J, Lai D, Landén M, Hellard SL, Leboyer M, Lochner C, McCracken JT, Medland SE, Mortensen PB, Neale BM, Nicolini H, Nordentoft M, Pato M, Pato C, Pauls DL, Piacentini J, Pittenger C, Posthuma D, Ramos-Quiroga JA, Rasmussen SA, Richter MA, Rosenberg DR, Ruhrmann S, Samuels JF, Sandin S, Sandor P, Spalletta G, Stein DJ, Stewart SE, Storch EA, Stranger BE, Turiel M, Werge T, Andreassen OA, Børglum AD, Walitza S, Hveem K, Hansen BK, Rück C, Martin NG, Milani L, Mors O, Reichborn-Kjennerud T, Ribasés M, Kvale G, Mataix-Cols D, Domschke K, Grünblatt E, Wagner M, Zwart JA, Breen G, Nestadt G, Kaprio J, Arnold PD, Grice DE, Knowles JA, Ask H, Verweij KJ, Davis LK, Smit DJ, Crowley JJ, Scharf JM, Stein MB, Gelernter J, Mathews CA, Derks EM, Mattheisen M. Nat Genet. 2025 Jun; 2025 May 13. PMID: 40360802.
• Racial Implicit Associations in Child Psychiatry.Malison KA, Avila-Quintero VJ, Al-Mateen CS, Flores J, Landeros-Weisenberger A, Njoroge WFM, Novins DK, Robles-Ramamurthy B, Taylor JH, Bloch MH, Tobón AL. J Am Acad Child Adolesc Psychiatry. 2025 Jun; 2024 May 30. PMID: 38823476.
• Analyzing the Contents of a Large, Public Online Peer Support Forum for Obsessive-Compulsive Disorder: Thematic Analysis.Sun NY, Pittenger C, Ching T. JMIR Form Res. 2025 May 26; 2025 May 26. PMID: 40418853.
• Neurospectrum: A Geometric and Topological Deep Learning Framework for Uncovering Spatiotemporal Signatures in Neural Activity.Bhaskar D, Zhang Y, Moore J, Gao F, Rieck B, Wolf G, Khasawneh F, Munch E, Noah JA, Pushkarskaya H, Pittenger C, Greco V, Krishnaswamy S. bioRxiv. 2025 May 8; 2025 May 8. PMID: 40654845.
• Systematic Review and Meta-Analysis: Placebo Response in Randomized Controlled Trials of Tourette's Disorder Medications.Macul Ferreira de Barros P, Farhat LC, Behling E, Nasir M, Landeros-Weisenberger A, Bloch MH. J Am Acad Child Adolesc Psychiatry. 2025 May; 2024 Nov 4. PMID: 39505141.
• Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.Strom NI, Gerring ZF, Galimberti M, Yu D, Halvorsen MW, Abdellaoui A, Rodriguez-Fontenla C, Sealock JM, Bigdeli T, Coleman JR, Mahjani B, Thorp JG, Bey K, Burton CL, Luykx JJ, Zai G, Alemany S, Andre C, Askland KD, Bäckmann J, Banaj N, Barlassina C, Nissen JB, Bienvenu OJ, Black D, Bloch MH, Børte S, Bosch R, Breen M, Brennan BP, Brentani H, Buxbaum JD, Bybjerg-Grauholm J, Byrne EM, Cabana-Dominguez J, Camarena B, Camarena A, Cappi C, Carracedo A, Casas M, Cavallini MC, Ciullo V, Cook EH, Crosby J, Cullen BA, De Schipper EJ, Delorme R, Djurovic S, Elias JA, Estivill X, Falkenstein MJ, Fundin BT, Garner L, Gironda C, Goes FS, Grados MA, Grove J, Guo W, Haavik J, Hagen K, Harrington K, Havdahl A, Höffler KD, Hounie AG, Hucks D, Hultman C, Janecka M, Jenike E, Karlsson EK, Kelley K, Klawohn J, Krasnow JE, Krebs K, Lange C, Lanzagorta N, Levey D, Lindblad-Toh K, Macciardi F, Maher B, Mathes B, McArthur E, McGregor N, McLaughlin NC, Meier S, Miguel EC, Mulhern M, Nestadt PS, Nurmi EL, O'Connell KS, Osiecki L, Ousdal OT, Palviainen T, Pedersen NL, Piras F, Piras F, Potluri S, Rabionet R, Ramirez A, Rauch S, Reichenberg A, Riddle MA, Ripke S, Rosário MC, Sampaio AS, Schiele MA, Skogholt AH, Sloofman LG, Smit J, Soler Artigas M, Thomas LF, Tifft E, Vallada H, van Kirk N, Veenstra-VanderWeele J, Vulink NN, Walker CP, Wang Y, Wendland JR, Winsvold BS, Yao Y, Zhou H, Agrawal A, Alonso P, Berberich G, Bucholz KK, Bulik CM, Cath D, Denys D, Eapen V, Edenberg H, Falkai P, Fernandez TV, Fyer AJ, Gaziano JM, Geller DA, Grabe HJ, Greenberg BD, Hanna GL, Hickie IB, Hougaard DM, Kathmann N, Kennedy J, Lai D, Landén M, Le Hellard S, Leboyer M, Lochner C, McCracken JT, Medland SE, Mortensen PB, Neale BM, Nicolini H, Nordentoft M, Pato M, Pato C, Pauls DL, Piacentini J, Pittenger C, Posthuma D, Ramos-Quiroga JA, Rasmussen SA, Richter MA, Rosenberg DR, Ruhrmann S, Samuels JF, Sandin S, Sandor P, Spalletta G, Stein DJ, Stewart SE, Storch EA, Stranger BE, Turiel M, Werge T, Andreassen OA, Børglum AD, Walitza S, Hveem K, Hansen BK, Rück C, Martin NG, Milani L, Mors O, Reichborn-Kjennerud T, Ribasés M, Kvale G, Mataix-Cols D, Domschke K, Grünblatt E, Wagner M, Zwart JA, Breen G, Nestadt G, Kaprio J, Arnold PD, Grice DE, Knowles JA, Ask H, Verweij KJ, Davis LK, Smit DJ, Crowley JJ, Scharf JM, Stein MB, Gelernter J, Mathews CA, Derks EM, Mattheisen M. medRxiv. 2025 Apr 8; 2025 Apr 8. PMID: 38712091.
• Making Progress in Clinical Trials for Suicide Prevention: A Review.Wilkinson ST, Bryan CJ, Alphs LD, Canuso CM, Ostacher MJ, Price RB, Bloch MH, Zarate CA, Rhee TG. JAMA Psychiatry. 2025 Apr 1. PMID: 39937491.
• Sexual dimorphism in histamine regulation of striatal dopamine.Van Zandt M, Pittenger C. bioRxiv. 2025 Feb 28; 2025 Feb 28. PMID: 38826392.
• Editorial: Adolescent Eating Disorders Are Increasing and We Need to Do More.Kamody RC, Bloch MH. J Am Acad Child Adolesc Psychiatry. 2025 Feb; 2024 May 20. PMID: 38777314.
• Editorial: From adolescence into young adulthood - the importance of a longitudinal perspective across development in child and adolescent mental health.Koenig J, Farhat LC, Bloch MH. J Child Psychol Psychiatry. 2025 Jan. PMID: 39690123.
• Psychedelic medicine in psychiatry residency training: a survey of psychiatric residency program directors.Yaden ME, Ching THW, Goldway N, Roberts DE, Hokanson J, Gukasyan N, Pittenger C, Kelmendi B, Ross S, Glick G, O'Donnell KC. Int Rev Psychiatry. 2024 Dec; 2024 Sep 11. PMID: 39980219.
• Circuit mechanisms underlying sexually dimorphic outcomes of early life stress.Jiang C, Ruiz-Sanchez I, Mei C, Pittenger C. bioRxiv. 2024 Nov 28; 2024 Nov 28. PMID: 39651173.
• Pharmacological Interventions for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Tourette Disorder: A Systematic Review and Network Meta-Analysis.Farhat LC, Behling E, Landeros-Weisenberger A, Macul Ferreira de Barros P, Polanczyk GV, Cortese S, Bloch MH. J Child Adolesc Psychopharmacol. 2024 Nov; 2024 Sep 24. PMID: 39320340.
• Elevated antibody binding to striatal cholinergic interneurons in patients with pediatric acute-onset neuropsychiatric syndrome.Xu J, Frankovich J, Liu RJ, Thienemann M, Silverman M, Farhadian B, Willett T, Manko C, Columbo L, Leibold C, Vaccarino FM, Che A, Pittenger C. Brain Behav Immun. 2024 Nov; 2024 Jul 30. PMID: 39084540.
• The human claustrum tracks slow waves during sleep.Lamsam L, Gu B, Liang M, Sun G, Khan KJ, Sheth KN, Hirsch LJ, Pittenger C, Kaye AP, Krystal JH, Damisah EC. Nat Commun. 2024 Oct 17; 2024 Oct 17. PMID: 39419999.
• Activation of M(4) muscarinic receptors in the striatum reduces tic-like behaviours in two distinct murine models of Tourette syndrome.Cadeddu R, Braccagni G, Branca C, van Luik ER, Pittenger C, Thomsen MS, Bortolato M. Br J Pharmacol. 2024 Sep; 2024 Apr 30. PMID: 38689378.
• Externally orienting cues improve cognitive control in OCD.Bednarek L, Glover S, Ma X, Pittenger C, Pushkarskaya H. J Behav Ther Exp Psychiatry. 2024 Sep; 2024 Mar 14. PMID: 38531125.
• Sex differences in the distribution and density of regulatory interneurons in the striatum.Van Zandt M, Flanagan D, Pittenger C. Front Cell Neurosci. 2024; 2024 Jul 8. PMID: 39045533.
• The effects of Shaoma Zhijing granules and its main components on Tourette syndrome.Zhao Q, Hu Y, Yan Y, Song X, Yu J, Wang W, Zhou S, Su X, Bloch MH, Leckman JF, Chen Y, Sun H. Phytomedicine. 2024 Jul; 2024 Apr 26. PMID: 38759346.
• Mechanisms of therapeutic change after psychedelic treatment in OCD.Maloney G, Ching T, Kichuk SA, Pittenger C, Kelmendi B. Psychiatry Res. 2024 Jun; 2024 Apr 7. PMID: 38615521.
• Information processing style and institutional trust as factors of COVID vaccine hesitancy.Zhao W, Russell CM, Jankovsky A, Cannon TD, Pittenger C, Pushkarskaya H. Sci Rep. 2024 May 6; 2024 May 6. PMID: 38710827.
• An evaluation of treatment response and remission definitions in adult obsessive-compulsive disorder: A systematic review and individual-patient data meta-analysis.Ramakrishnan D, Farhat LC, Vattimo EFQ, Levine JLS, Johnson JA, Artukoglu BB, Landeros-Weisenberger A, Zangen A, Pelissolo A, de B Pereira CA, Rück C, Costa DLC, Mataix-Cols D, Shannahoff-Khalsa D, Tolin DF, Zarean E, Meyer E, Hawken ER, Storch EA, Andersson E, Miguel EC, Maina G, Leckman JF, Sarris J, March JS, Diniz JB, Kobak K, Mallet L, Vulink NCC, Amiaz R, Fernandes RY, Shavitt RG, Wilhelm S, Golshan S, Tezenas du Montcel S, Erzegovesi S, Baruah U, Greenberg WM, Kobayashi Y, Bloch MH. J Psychiatr Res. 2024 May; 2024 Mar 29. PMID: 38598877.
• Post-event rumination and social anxiety: a systematic review and meta-analysis.Edgar EV, Richards A, Castagna PJ, Bloch MH, Crowley MJ. J Psychiatr Res. 2024 May; 2024 Mar 15. PMID: 38518572.
• Sex differences in the distribution and density of regulatory interneurons in the striatum.Van Zandt M, Flanagan D, Pittenger C. bioRxiv. 2024 Apr 9; 2024 Apr 9. PMID: 38464268.
• Correction: White matter diffusion estimates in obsessive-compulsive disorder across 1653 individuals: machine learning findings from the ENIGMA OCD Working Group.Kim BG, Kim G, Abe Y, Alonso P, Ameis S, Anticevic A, Arnold PD, Balachander S, Banaj N, Bargalló N, Batistuzzo MC, Benedetti F, Bertolín S, Beucke JC, Bollettini I, Brem S, Brennan BP, Buitelaar JK, Calvo R, Castelo-Branco M, Cheng Y, Chhatkuli RB, Ciullo V, Coelho A, Couto B, Dallaspezia S, Ely BA, Ferreira S, Fontaine M, Fouche JP, Grazioplene R, Gruner P, Hagen K, Hansen B, Hanna GL, Hirano Y, Höxter MQ, Hough M, Hu H, Huyser C, Ikuta T, Jahanshad N, James A, Jaspers-Fayer F, Kasprzak S, Kathmann N, Kaufmann C, Kim M, Koch K, Kvale G, Kwon JS, Lazaro L, Lee J, Lochner C, Lu J, Manrique DR, Martínez-Zalacaín I, Masuda Y, Matsumoto K, Maziero MP, Menchón JM, Minuzzi L, Moreira PS, Morgado P, Narayanaswamy JC, Narumoto J, Ortiz AE, Ota J, Pariente JC, Perriello C, Picó-Pérez M, Pittenger C, Poletti S, Real E, Reddy YCJ, van Rooij D, Sakai Y, Sato JR, Segalas C, Shavitt RG, Shen Z, Shimizu E, Shivakumar V, Soreni N, Soriano-Mas C, Sousa N, Sousa MM, Spalletta G, Stern ER, Stewart SE, Szeszko PR, Thomas R, Thomopoulos SI, Vecchio D, Venkatasubramanian G, Vriend C, Walitza S, Wang Z, Watanabe A, Wolters L, Xu J, Yamada K, Yun JY, Zarei M, Zhao Q, Zhu X, Thompson PM, Bruin WB, van Wingen GA, Piras F, Piras F, Stein DJ, van den Heuvel OA, Simpson HB, Marsh R, Cha J. Mol Psychiatry. 2024 Apr. PMID: 38454086.
• White matter diffusion estimates in obsessive-compulsive disorder across 1653 individuals: machine learning findings from the ENIGMA OCD Working Group.Kim BG, Kim G, Abe Y, Alonso P, Ameis S, Anticevic A, Arnold PD, Balachander S, Banaj N, Bargalló N, Batistuzzo MC, Benedetti F, Bertolín S, Beucke JC, Bollettini I, Brem S, Brennan BP, Buitelaar JK, Calvo R, Castelo-Branco M, Cheng Y, Chhatkuli RB, Ciullo V, Coelho A, Couto B, Dallaspezia S, Ely BA, Ferreira S, Fontaine M, Fouche JP, Grazioplene R, Gruner P, Hagen K, Hansen B, Hanna GL, Hirano Y, Höxter MQ, Hough M, Hu H, Huyser C, Ikuta T, Jahanshad N, James A, Jaspers-Fayer F, Kasprzak S, Kathmann N, Kaufmann C, Kim M, Koch K, Kvale G, Kwon JS, Lazaro L, Lee J, Lochner C, Lu J, Manrique DR, Martínez-Zalacaín I, Masuda Y, Matsumoto K, Maziero MP, Menchón JM, Minuzzi L, Moreira PS, Morgado P, Narayanaswamy JC, Narumoto J, Ortiz AE, Ota J, Pariente JC, Perriello C, Picó-Pérez M, Pittenger C, Poletti S, Real E, Reddy YCJ, van Rooij D, Sakai Y, Sato JR, Segalas C, Shavitt RG, Shen Z, Shimizu E, Shivakumar V, Soreni N, Soriano-Mas C, Sousa N, Sousa MM, Spalletta G, Stern ER, Stewart SE, Szeszko PR, Thomas R, Thomopoulos SI, Vecchio D, Venkatasubramanian G, Vriend C, Walitza S, Wang Z, Watanabe A, Wolters L, Xu J, Yamada K, Yun JY, Zarei M, Zhao Q, Zhu X, Thompson PM, Bruin WB, van Wingen GA, Piras F, Piras F, Stein DJ, van den Heuvel OA, Simpson HB, Marsh R, Cha J. Mol Psychiatry. 2024 Apr; 2024 Feb 7. PMID: 38326559.
• Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression.Lineham A, Avila-Quintero VJ, Bloch MH, Dwyer J. J Child Adolesc Psychopharmacol. 2024 Mar; 2024 Jan 3. PMID: 38170185.
• A novel naïve Bayes approach to identifying grooming behaviors in the force-plate actometric platform.Anderson CJ, Cadeddu R, Anderson DN, Huxford JA, VanLuik ER, Odeh K, Pittenger C, Pulst SM, Bortolato M. J Neurosci Methods. 2024 Mar; 2023 Nov 28. PMID: 38029972.
• Sexual Orientation and Racial Bias in Relation to Medical Specialty.Zelin NS, Scott C, Avila-Quintero VJ, Curlin K, Flores JM, Bloch MH. J Homosex. 2024 Feb 23; 2022 Oct 21. PMID: 36269161.
• Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B. Front Psychiatry. 2024; 2024 Feb 16. PMID: 38435972.
• The endogenous opioid system in the medial prefrontal cortex mediates ketamine's antidepressant-like actions.Jiang C, DiLeone RJ, Pittenger C, Duman RS. Transl Psychiatry. 2024 Feb 12; 2024 Feb 12. PMID: 38346984.
• Family accommodation: a diagnostic feature of obsessive-compulsive disorder?Etkin RG, Bloch MH, Lebowitz ER. Expert Rev Neurother. 2024 Feb; 2024 Feb 6. PMID: 38258501.
• Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.Farhat LC, Flores JM, Avila-Quintero VJ, Polanczyk GV, Cipriani A, Furukawa TA, Bloch MH, Cortese S. JAMA Psychiatry. 2024 Feb 1. PMID: 37878348.
• The human claustrum tracks slow waves during sleep.Lamsam L, Liang M, Gu B, Sun G, Hirsch LJ, Pittenger C, Kaye AP, Krystal JH, Damisah EC. bioRxiv. 2024 Jan 30; 2024 Jan 30. PMID: 38352615.
• A comparison of machine learning methods for quantifying self-grooming behavior in mice.Correia K, Walker R, Pittenger C, Fields C. Front Behav Neurosci. 2024; 2024 Jan 29. PMID: 38347909.
• Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B. Front Psychiatry. 2023; 2024 Jan 9. PMID: 38264632.
• What Is in a Name? The Many Meanings of "Psychedelic".O'Donnell KC, Roberts DE, Ching THW, Glick G, Goldway N, Gukasyan N, Hokansen J, Kelmendi B, Ross S, Yaden ME, Pittenger C. Psychedelic Med (New Rochelle). 2023 Dec; 2023 Dec 13. PMID: 40046863.
• Pharmacotherapy for comorbid antisocial personality and obsessive-compulsive disorder: A case report.Jankovsky A, Zaboski B, Pittenger C. Psychiatry Res Case Rep. 2023 Dec; 2023 Jun 25. PMID: 38240012.
• Frontopolar multifocal transcranial direct current stimulation reduces conditioned fear reactivity during extinction training: A pilot randomized controlled trial.Adams TG, Kelmendi B, George JR, Forte J, Hubert TJJ, Wild H, Rippey CS, Pittenger C. Neurobiol Learn Mem. 2023 Nov; 2023 Sep 10. PMID: 37699439.
• The endogenous opioid system in the medial prefrontal cortex mediates ketamine's antidepressant-like actions.Pittenger C, Jiang C, DiLeone R, Duman R. Res Sq. 2023 Oct 3; 2023 Oct 3. PMID: 37886526.
• Neurofeedback for obsessive compulsive disorder: A randomized, double-blind trial.Rance M, Zhao Z, Zaboski B, Kichuk SA, Romaker E, Koller WN, Walsh C, Harris-Starling C, Wasylink S, Adams T Jr, Gruner P, Pittenger C, Hampson M. Psychiatry Res. 2023 Oct; 2023 Sep 3. PMID: 37722238.
• Correction: The functional connectome in obsessive-compulsive disorder: resting-state mega-analysis and machine learning classification for the ENIGMA-OCD consortium.Bruin WB, Abe Y, Alonso P, Anticevic A, Backhausen LL, Balachander S, Bargallo N, Batistuzzo MC, Benedetti F, Bertolin Triquell S, Brem S, Calesella F, Couto B, Denys DAJP, Echevarria MAN, Eng GK, Ferreira S, Feusner JD, Grazioplene RG, Gruner P, Guo JY, Hagen K, Hansen B, Hirano Y, Hoexter MQ, Jahanshad N, Jaspers-Fayer F, Kasprzak S, Kim M, Koch K, Bin Kwak Y, Kwon JS, Lazaro L, Li CR, Lochner C, Marsh R, Martínez-Zalacaín I, Menchon JM, Moreira PS, Morgado P, Nakagawa A, Nakao T, Narayanaswamy JC, Nurmi EL, Zorrilla JCP, Piacentini J, Picó-Pérez M, Piras F, Piras F, Pittenger C, Reddy JYC, Rodriguez-Manrique D, Sakai Y, Shimizu E, Shivakumar V, Simpson BH, Soriano-Mas C, Sousa N, Spalletta G, Stern ER, Evelyn Stewart S, Szeszko PR, Tang J, Thomopoulos SI, Thorsen AL, Yoshida T, Tomiyama H, Vai B, Veer IM, Venkatasubramanian G, Vetter NC, Vriend C, Walitza S, Waller L, Wang Z, Watanabe A, Wolff N, Yun JY, Zhao Q, van Leeuwen WA, van Marle HJF, van de Mortel LA, van der Straten A, van der Werf YD, Thompson PM, Stein DJ, van den Heuvel OA, van Wingen GA. Mol Psychiatry. 2023 Oct. PMID: 37582859.
• The functional connectome in obsessive-compulsive disorder: resting-state mega-analysis and machine learning classification for the ENIGMA-OCD consortium.Bruin WB, Abe Y, Alonso P, Anticevic A, Backhausen LL, Balachander S, Bargallo N, Batistuzzo MC, Benedetti F, Bertolin Triquell S, Brem S, Calesella F, Couto B, Denys DAJP, Echevarria MAN, Eng GK, Ferreira S, Feusner JD, Grazioplene RG, Gruner P, Guo JY, Hagen K, Hansen B, Hirano Y, Hoexter MQ, Jahanshad N, Jaspers-Fayer F, Kasprzak S, Kim M, Koch K, Bin Kwak Y, Kwon JS, Lazaro L, Li CR, Lochner C, Marsh R, Martínez-Zalacaín I, Menchon JM, Moreira PS, Morgado P, Nakagawa A, Nakao T, Narayanaswamy JC, Nurmi EL, Zorrilla JCP, Piacentini J, Picó-Pérez M, Piras F, Piras F, Pittenger C, Reddy JYC, Rodriguez-Manrique D, Sakai Y, Shimizu E, Shivakumar V, Simpson BH, Soriano-Mas C, Sousa N, Spalletta G, Stern ER, Evelyn Stewart S, Szeszko PR, Tang J, Thomopoulos SI, Thorsen AL, Yoshida T, Tomiyama H, Vai B, Veer IM, Venkatasubramanian G, Vetter NC, Vriend C, Walitza S, Waller L, Wang Z, Watanabe A, Wolff N, Yun JY, Zhao Q, van Leeuwen WA, van Marle HJF, van de Mortel LA, van der Straten A, van der Werf YD, Thompson PM, Stein DJ, van den Heuvel OA, van Wingen GA. Mol Psychiatry. 2023 Oct; 2023 May 2. PMID: 37131072.
• Pleiotropic Association of CACNA1C Variants With Neuropsychiatric Disorders.Wang Z, Lin X, Luo X, Xiao J, Zhang Y, Xu J, Wang S, Zhao F, Wang H, Zheng H, Zhang W, Lin C, Tan Z, Cao L, Wang Z, Tan Y, Chen W, Cao Y, Guo X, Pittenger C, Luo X. Schizophr Bull. 2023 Sep 7. PMID: 37306960.
• Editorial: Developmental considerations in addressing the earlier age of severe eating disorder onset.Kamody RC, Bloch MH. J Child Psychol Psychiatry. 2023 Aug. PMID: 37408467.
• Prefrontal allopregnanolone mediates the adverse effects of acute stress in a mouse model of tic pathophysiology.Cadeddu R, Van Zandt M, Santovito LS, Odeh K, Anderson CJ, Flanagan D, Nordkild P, Pinna G, Pittenger C, Bortolato M. Neuropsychopharmacology. 2023 Aug; 2023 May 17. PMID: 37198434.
• 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice.Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Woodburn SC, Wehrle PH, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC. Neuropsychopharmacology. 2023 Aug; 2023 Apr 4. PMID: 37015972.
• A novel naïve Bayes approach to identifying grooming behaviors in the force-plate actometric platform.Anderson CJ, Cadeddu R, Anderson DN, Huxford JA, VanLuik ER, Odeh K, Pittenger C, Pulst SM, Bortolato M. bioRxiv. 2023 Jul 12; 2023 Jul 12. PMID: 37503098.
• Prevalence and gender distribution of excoriation (skin-picking) disorder: A systematic review and meta-analysis.Farhat LC, Reid M, Bloch MH, Olfson E. J Psychiatr Res. 2023 May; 2023 Apr 1. PMID: 37023597.
• Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.Ching THW, Grazioplene R, Bohner C, Kichuk SA, DePalmer G, D'Amico E, Eilbott J, Jankovsky A, Burke M, Hokanson J, Martins B, Witherow C, Patel P, Amoroso L, Schaer H, Pittenger C, Kelmendi B. Front Psychiatry. 2023; 2023 Apr 25. PMID: 37181888.
• Pharmacological and Somatic Treatment Effects on Suicide in Adults: A Systematic Review and Meta-Analysis.Wilkinson ST, Trujillo Diaz D, Rupp ZW, Kidambi A, Ramirez KL, Flores JM, Avila-Quintero VJ, Rhee TG, Olfson M, Bloch MH. Focus (Am Psychiatr Publ). 2023 Apr; 2023 Apr 14. PMID: 37201149.
• The histamine H3 receptor modulates dopamine D2 receptor-dependent signaling pathways and mouse behaviors.Xu J, Pittenger C. J Biol Chem. 2023 Apr; 2023 Mar 4. PMID: 36871761.
• Characteristics of trichotillomania and excoriation disorder across the lifespan.Lin A, Farhat LC, Flores JM, Levine JLS, Fernandez TV, Bloch MH, Olfson E. Psychiatry Res. 2023 Apr; 2023 Feb 21. PMID: 36842397.
• Revisiting best practices: a reflection on the online evaluation and treatment of ADHD and implications for future practice.Rolison MJ, Bloch MH. Child Adolesc Psychiatry Ment Health. 2023 Mar 28; 2023 Mar 28. PMID: 36978153.
• Neuroinflammation in Obsessive-Compulsive Disorder: Sydenham Chorea, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections, and Pediatric Acute Onset Neuropsychiatric Syndrome.Vreeland A, Thienemann M, Cunningham M, Muscal E, Pittenger C, Frankovich J. Psychiatr Clin North Am. 2023 Mar. PMID: 36740356.
• The Pharmacological Treatment of Obsessive-Compulsive Disorder.Pittenger C. Psychiatr Clin North Am. 2023 Mar; 2023 Jan 4. PMID: 36740347.
• The Relationship Between Acute Dissociative Effects Induced by Ketamine and Treatment Response in Adolescent Patients with Treatment-Resistant Depression.Lineham A, Avila-Quintero VJ, Bloch MH, Dwyer J. J Child Adolesc Psychopharmacol. 2023 Feb. PMID: 36799961.
• Systematic review and meta-analysis: Season of birth and schizophrenia risk.Coury SM, Lombroso A, Avila-Quintero VJ, Taylor JH, Flores JM, Szejko N, Bloch MH. Schizophr Res. 2023 Feb; 2023 Jan 20. PMID: 36682315.
• Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis.Farhat LC, Behling E, Landeros-Weisenberger A, Levine JLS, Macul Ferreira de Barros P, Wang Z, Bloch MH. Lancet Child Adolesc Health. 2023 Feb; 2022 Dec 14. PMID: 36528030.
• Cholinergic neurons in the basal forebrain are involved in behavioral abnormalities associated with Cul3 deficiency: Role of prefrontal cortex projections in cognitive deficits.Rapanelli M, Wang W, Hurley E, Feltri ML, Pittenger C, Frick LR, Yan Z. Transl Psychiatry. 2023 Jan 24; 2023 Jan 24. PMID: 36693858.
• Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity.Warner-Schmidt J, Pittenger C, Stogniew M, Mandell B, Olmstead SJ, Kelmendi B. Front Psychiatry. 2022; 2023 Jan 10. PMID: 36704743.
• Postinfectious Inflammation, Autoimmunity, and Obsessive-Compulsive Disorder: Sydenham Chorea, Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection, and Pediatric Acute-Onset Neuropsychiatric Disorder.Vreeland A, Calaprice D, Or-Geva N, Frye RE, Agalliu D, Lachman HM, Pittenger C, Pallanti S, Williams K, Ma M, Thienemann M, Gagliano A, Mellins E, Frankovich J. Dev Neurosci. 2023; 2023 Sep 22. PMID: 37742615.
• Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.Kelmendi B, Kichuk SA, DePalmer G, Maloney G, Ching THW, Belser A, Pittenger C. Heliyon. 2022 Dec; 2022 Dec 6. PMID: 36536916.
• Characterization of human basal ganglia organoids.Brady MV, Mariani J, Koca Y, Szekely A, King RA, Bloch MH, Landeros-Weisenberger A, Leckman JF, Vaccarino FM. Mol Psychiatry. 2022 Dec. PMID: 36536052.
• Mispatterning and interneuron deficit in Tourette Syndrome basal ganglia organoids.Brady MV, Mariani J, Koca Y, Szekely A, King RA, Bloch MH, Landeros-Weisenberger A, Leckman JF, Vaccarino FM. Mol Psychiatry. 2022 Dec; 2022 Nov 29. PMID: 36447010.
• White matter abnormalities in the Hdc knockout mouse, a model of tic and OCD pathophysiology.Jindachomthong K, Yang C, Huang Y, Coman D, Rapanelli M, Hyder F, Dougherty J, Frick L, Pittenger C. Front Mol Neurosci. 2022; 2022 Nov 24. PMID: 36504678.
• Prevalence and gender distribution of trichotillomania: A systematic review and meta-analysis.Thomson HA, Farhat LC, Olfson E, Levine JLS, Bloch MH. J Psychiatr Res. 2022 Sep; 2022 Jul 1. PMID: 35802953.
• Obsessive compulsive symptom dimensions are linked to altered white-matter microstructure in a community sample of youth.Grazioplene RG, DeYoung CG, Hampson M, Anticevic A, Pittenger C. Transl Psychiatry. 2022 Aug 10; 2022 Aug 10. PMID: 35948535.
• Editorial: Schools on the frontline of suicide prevention.Kamody RC, Bloch MH. J Child Psychol Psychiatry. 2022 Aug. PMID: 35861181.
• Editorial: We Can Do Better: Meta-analysis Demonstrates Inequities in Psychotherapy Efficacy for Black Children.Bloch MH, Finch K. J Am Acad Child Adolesc Psychiatry. 2022 Jun; 2022 Mar 26. PMID: 35346785.
• Parental age and the risk of bipolar disorder in the offspring: A systematic review and meta-analysis.Polga N, Macul Ferreira de Barros P, Farhat LC, de Almeida KM, Bloch MH, Lafer B. Acta Psychiatr Scand. 2022 Jun; 2022 Mar 7. PMID: 35188977.
• Correction: Mapping brain-behavior space relationships along the psychosis spectrum.Ji JL, Helmer M, Fonteneau C, Burt JB, Tamayo Z, Demšar J, Adkinson BD, Savić A, Preller KH, Moujaes F, Vollenweider FX, Martin WJ, Repovš G, Cho YT, Pittenger C, Murray JD, Anticevic A. Elife. 2022 Apr 5; 2022 Apr 5. PMID: 35380951.
• Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.Dwyer JB, Landeros-Weisenberger A, Johnson JA, Londono Tobon A, Flores JM, Nasir M, Couloures K, Sanacora G, Bloch MH. Focus (Am Psychiatr Publ). 2022 Apr; 2022 Apr 22. PMID: 37153136.
• Meta-Analysis: Efficacy and Tolerability of Vesicular Monoamine Transporter Type 2 Inhibitors in the Treatment of Tic Disorders.Behling E, Farhat LC, Landeros-Weisenberger A, Bloch MH. Mov Disord. 2022 Apr; 2022 Feb 22. PMID: 35191552.